Written by Eric Akasa
Merck a company dealing with innovative and top-quality high-tech products in the pharmaceutical, chemical and life-science sectors has partnered with Kenya Medical Research Institution (KEMRI) for a scientific partnership aimed at contributing to the country’s social and economic development. The partnership will cover research and development projects, programs and activities focused on malaria and schistosomiasis, as well as related co-infections.
Written by Raymond Gichuki
India plans to adopt the successful European accredited Diabetes Management course by Merck- the world’s oldest pharmaceutical and chemical company. This is after a successful introduction of the course in Africa in partnership with eight African universities and Ministries of Health to medical and pharmacy students.
Written by Kevin Wafula
Health Kenyan and Gabonese volunteers are needed to take part in candidate Ebola vaccines trials. With funds from the Wellcome Trust, an international consortium to accelerate development of the VSV Ebola vaccine, rVSV-EBOV has already been set up to fast-track early tests of candidate Ebola vaccines so that they could be available for trial in West Africa by the end of the year, and if successful deployed more widely in 2015.
Page 1 of 71